A polymer-type water-soluble peptidoglycan exhibited both Toll-like receptor 2- and NOD2-agonistic activities,resulting in synergistic activation of human monocytic cells
Free accessOtherFirst published online October, 2008
A polymer-type water-soluble peptidoglycan exhibited both Toll-like receptor 2- and NOD2-agonistic activities,resulting in synergistic activation of human monocytic cells
Bacterial peptidoglycan (PGN) has been reported to be sensed by cell-surface Toll-like receptor (TLR)2. On the other hand, intracellular NOD-like receptors recognize PGN partial structures: NOD1 and NOD2 recognize the peptide moiety containing diaminopimelic acid, and the muramyldipeptide (MDP) moiety, respectively. In this study, we examined in human monocytic THP-1 cells the pro-inflammatory cytokine-inducing abilities of PGNs and their fragments enzymatically prepared from Staphylococcus epidermidis ATCC 155: a polymer-type water-soluble PGN possessing an intact glycan chain (SEPS) and a monomer-type PGN (SEPS-M). The water-soluble PGN polymer, SEPS, exhibited considerably stronger activities to induce pro-inflammatory cytokines than parent PGNs and the PGN monomer, SEPS-M. Short interference RNA targeting TLR2 and NOD2 markedly reduced the activities of SEPS. In the same experiments, the activities of PGNs were mainly reduced in TLR2-silenced cells, whereas the activities of SEPS-M as well as a synthetic MDP were markedly reduced in NOD2-silenced cells. Furthermore, the PGNs and a reference PGN from Staphylococcus aureus in combination with MDP synergistically induced interleukin-8 in THP-1 cells. These findings strongly suggested that a polymer-type water-soluble PGN fragment, SEPS, exhibits both TLR2-and NOD2-agonistic activities, which induced the synergistic activation of human monocytic cells.
Seidl PH, Schleifer KH. (eds) Biological properties of peptidoglycan . Berlin: Water de Gruyter, 1986; 1-436.
2.
Schleifer KH , Kandler O.Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev1972; 36: 407-477.
3.
Ellouz F., Adam A., Ciorbaru R., Lederer E.Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun1974 ; 59: 1317-1325.
4.
Kotani S., Watanabe Y., Kinoshita F. et al. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids. Biken J1975; 18: 105-111.
5.
Takada H., Uehara A.Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling. Curr Pharma Des2006 ; 12: 4163-4172.
6.
Inohara N., Ogura Y., Fontalba A. et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J Biol Chem2003; 278: 5509-5512.
7.
Girardin SE, Boneca IG, Viala J. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem2003; 278: 8869-8872.
8.
Chamaillard M., Hashimoto M., Horie Y. et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol2003; 4: 702-707.
9.
Girardin SE, Boneca IG, Carneiro LAM et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science2003; 300: 1584-1587.
Takeuchi O. , Hoshino K., Kawai T. et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components . Immunity1999; 11: 443-451.
12.
Yoshimura A. , Lien E., Ingalls RR, Tuomanen E., Dziarski R., Golenbock D.Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol1999;163: 1-5.
13.
Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning CJPeptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem1999; 274: 17406- 17409.
14.
Netea MG, Ferwerda G., de Jong DJ et al. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol2005; 174: 6518-6523.
15.
Travassos LH , Girardin SE, Philpott DJ et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition . EMBO Report2004; 5: 1000-1006.
16.
Vidal VF, Castéran N., Riendeau CJ et al. Macrophage stimulation with murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPβ and STAT1: role of CD14 and Toll-like receptor 2 and 4 . Eur J Immunol2001; 31: 1962-1971.
17.
Yang S., Tamai R., Akashi S. et al. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun2001; 69: 2045-2053.
18.
Yoshimura A. , Takada H., Kaneko T., Kato I., Golenbock D., Hara Y.Structural requirements of muramylpeptides for induction of Toll-like receptor 2-mediated NF-κB activation in CHO cells. J Endotoxin Res2000 ; 6: 407-410.
19.
Dziarski R. , Gupta D.Staphylococcus aureus peptidoglycan is a Toll-like receptor 2 activator: a reevaluation. Infect Immun2005; 73: 5212-5216.
20.
Uehara A., Yang S., Fujimoto Y. et al. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol2005; 7: 53-61.
21.
Takada H., Tsujimoto M., Kotani S. et al. Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs . Infect Immun1979; 25: 645-652.
22.
Kawata S., Takemura T., Yokogawa K., Kotani S.Isolation of bacteriolytic endopeptidase from a strain of Cytophaga and its application to preparation of hydrosoluble polysaccharide peptide from Staphylococcus epidermidis peptidoglycan. Agric Biol Chem1984; 48: 2253-2263.
23.
Harada K., Kotani S., Takada H. et al. Liberation of serotonin from rabbit blood platelets by bacterial cell walls and related compounds. Infect Immun1982; 37: 1181-1190.
24.
Yokogawa K. , Kawata S., Takemura T., Yoshimura Y.Purification and properties of lytic enzymes from Streptomyces globisporus 1829. Agric Biol Chem1975; 39: 1533-1543.
25.
Hashimoto M. , Asai Y., Ogawara T.Separation and structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis . IntImmunol2004; 16: 1431-1437.
26.
Kubodera N., Sato K., Nishii Y.Characteristics of 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)-calcitriol (ED-71). In: Feldman D, Glorieux FH, Pike JW. (eds) Vitamin D. San Diego, CA: Academic Press, 1997; 1071-1086.
27.
Uehara A., Sugawara Y., Kurata S.et al. Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via Toll-like receptors, NOD1 and NOD2 in human oral epithelial cells. Cell Microbiol2005;7:675-686.
28.
Van Heel DA , Ghosh S., Butler M.et al. Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur J Immunol2005; 35: 2471-2476.
29.
Fritz JH, Girardin SE, Fitting C. et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol2005; 35: 2459-2470.
30.
Abbott DW, Yang Y., Hutti JE, Madhavarapu S., Kelliher MA, Cantley LCCoordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. Mol Cell Biol2007; 27: 6012-6025.
31.
Watanabe T. , Kitani A., Murray PJ, Strober W.NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol2004; 5: 800-808.
32.
Tada H., Aiba S., Shibata K., Ohteki T., Takada H.Synergistic effect of Nod1 and Nod2 agonists with Toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells . Infect Immun2005; 73: 7967-7976.
33.
Martinon F. , Agostini L., Meylan E., Tschopp J.Identification of bacterial muramyl dipeptide as activator of the NALP3/ Cryopyrin inflammasome . Curr Biol2004; 14: 1929-1934.
34.
Takeuchi O. , Kawai T., Mühlradt PF et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol2001; 13:933-940.
35.
Morath S., Stadelmaier A., Geyer A., Schmidt RR, Hartung T.Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J Exp Med2002 ; 195: 1635-1640.
36.
Schröder NWJ , Morath S., Alexander C. et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem2003; 278: 15587-15594.
37.
Zähringer U. , Lindner B., Inamura S., Heine H., Alexander C.TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology2008;213:205-224.
38.
Asai Y., Makimura Y., Kawabata A., Ogawa T.Soluble CD14 discriminates slight structural differences between lipid As that lead to distinct host cell activation. J Immunol2007; 179: 7674-7683.
39.
Kawasaki A., Takada H., Kotani S. et al. Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides - studies on active components and structural requirements . Microbiol Immunol1987; 31: 551-569.
40.
Myhre AE, Stuestøl JF, Dahle MK et al. Organ injury and cytokine release caused by peptidoglycan are dependent on the structural integrity of the glycan chain. Infect Immun2004; 72: 1311-1317.
41.
Wolfert MA, Murray TF, Boons G.-J, Moore JNThe origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J Biol Chem2002; 277: 39179-39186.
